Hyperbaric Oxygen Ambulance for Stroke Patients
Welcome to the Advancement of Acute Stroke Treatment with Ambulance based Hyperbaric Oxygen Research.
North Carolina has one of the highest stroke rates in the United States resulting in great disability, financial loss, and death to a large number of North Carolina citizens. In 2005 the total stroke hospital charges in North Carolina were $540 million. The average hospital charges per stroke patient stay in North Carolina in 2005 were $20,000. In 2005 there were 27,557 stroke patients discharged from North Carolina hospitals. In 2006 there were 4,551 stroke deaths in North Carolina. In 2008 the direct and indirect cost of stroke in the United States was $65.5 billion dollars.
We are developing a prototype Hyperbaric Oxygen Chamber equipped Stroke Treatment Ambulance. This prototype ambulance is being designed, built, and tested for safety, and the ambulance will become the foundation for a Phase II application to the National Institutes of Health to do human clinical trial testing necessary for FDA approval of the scientific principals outlined in our 2011 publication of successful hyperbaric oxygen human stroke treatment by McCormick, Houle, Saltzman, Whaley, and Roy. Our work is directed towards using ambulance based hyperbaric oxygen as a bridge to better acute stroke treatment with tPA for thousands more stroke patients each year.
Please donate and help us develop and build the first prototype hyperbaric oxygen acute stroke treatment ambulance.
As 501 (c) (3) non-profit organizations, Wake Forest Baptist Medical
Center and Wake Forest Health Sciences are compliant with the laws of
all 50 states and the District of Columbia regarding the solicitation
of charitable contributions.
Pressure (The Membership Newsletter of the Undersea & Hyperbaric Medical Society) is featuring an article, "Stroke Ambulance in Development", in the November/December 2013 publication about our work.
“Wake Forest Health Sciences of the Wake Forest Baptist Medical Center is working to help stroke patients in North Carolina. Their goals: to develop a prototype stroke treatment ambulance equipped with a hyperbaric oxygen chamber and to have it designated as an FDA-approved research vehicle…” Full Size Article
James G. McCormick, PhD
Director of Research, Aerospace, Hyperbaric & Undersea Medicine, Department of Anesthesiology
Past, Director of Research and Associate Professor of Otolaryngology, Wake Forest School of Medicine
Past, Chairman of Program Development for the World Federation of Neurology
Past, Visiting Professor of Psychology, Wake Forest University
Raymond C. Roy, MD, PhD
Former President, Wake Forest University Physicians
Professor of Anesthesiology
Former Chair of Anesthesiology
Department of Anesthesiology
Wake Forest University School of Medicine
“This research really excites me in two ways! First, it is a community-based project and that makes it unique. Second, if stroke symptoms can be reversed with hyperbaric oxygen, then embolus-dissolving therapy may be able to minimize the brain damage associated with the stroke. Outcomes could dramatically improve.” ~ Dr. Raymond Roy
Joseph R. Tobin, MD, FAAP, FCCM
Professor & Chairman, Department of Anesthesiology
Wake Forest University School of Medicine
Member, Wake Foreset Baptist Medical Center Board of Directors (2011-Present)
"Dr. Jim McCormick, Dr. Ray Roy, Dr. Tim Houle, and Dr. Quinn McCutchin in our Anesthesiology Department have pioneered a cutting edge translational science approach to improving acute stroke patient care for North Carolina and the United States. As I have participated in U.S. Navy planning meetings for this project, I have been extremely impressed with the world class talent that has come together from many disciplines to insure success of this invaluable project." ~ Dr. Joseph Tobin
Dr. Jim McCormick seen below in 1998 at an early Hyperbaric Oxygen Stroke Treatment Planning Meeting in Washington D.C. with Dr. James Toole and keynote speaker, Astronaut/U.S. Senator John Glenn. At this time Dr. Toole was Director of the Stroke Research Center and Professor of Neurology at Wake Forest School of Medicine and President of the World Federation of Neurology. John Glenn was the fist American astronaut to orbit the Earth in 1962. Shortly after appearing with Dr. McCormick and Dr. Toole in 1998, he returned to space on a Space Shuttle research mission.
Meeting: World Federation of Neurology Congress on Cerebral Ischemia, Vascular Dementia, Epilepsy and CNS Injury - New Aspects of Prevention and Treatment from Space and Underwater Explorations. Silver Plate reads: "Senator John Glenn - God Speed on your STS-95 Space Shuttle Flight - World Federation of Neurology."